Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation

Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation

AimsPermanent pacemaker implantation (PPI) combined with hypertension leads to a higher risk of new-onset atrial fibrillation (NOAF) for patients. Hence, it is essential to study how to reduce this risk. Currently, the effects of the two common anti-hypertensive drugs, angiotensin-converting enzyme...

Full description

Bibliographic Details
Main Authors: Zhijie Liu, Ning Bian, Shaorong Wu, Yantao Cao, Yiting Su, Wenying Li, Hairui Li, Xianwu Lan, Can Jiang, Yiming Fan, Jun Guo, Dongdong Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
pacemaker implantation
hypertension
angiotensin-converting enzyme inhibitors (ACEI)
angiotensin receptor blockers (ARB)
calcium channel blockers (CCB)
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1191539/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1191539/full

Similar Items